Primary and secondary endpoints
35.5–35.9
SECONDARY
The primary endpoint, CIT, did not differ between placebo and prednisone, 153 kcal/24 h (95% CI 40–266 kcal/24 h) and 186 kcal/24 h (94–277 kcal/24 h), respectively, p = 0.38, Study outcomes.Data presented as mean and 95% CI; treatment difference: prednisone - placebo.For the pre-specified secondary outcomes only the supraclavicular skin temperature was significantly lower after placebo treatment, 35.4 °C (95% CI: 35.2–35.6 °C), as compared to prednisone, 35.7 °C (95% CI, 35.5–35.9 °C, p = 0.0016). The results for the primary and secondary endpoints are given in 